• 

  Research data supporting "Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial": an adverse event case study from the "Adaptive study of IL-2 dose on regulatory T cells in Type 1 Diabetes (DILT1D) trial". 

  Waldron-Lynch, F
• 

  Data record for the secondary endpoint analysis of regulatory T cell phenotypes from the "Adaptive study of IL-2 dose on regulatory T cells in Type 1 Diabetes (DILT1D)" 

  Waldron-Lynch, F
• 

  Data record for adverse event case study: Adaptive study of IL-2 dose on regulatory T cells in Type 1 Diabetes (DILT1D) 

  Waldron-Lynch, Frank; TBC (University of Cambridge, 2016-01-11)
• 

  Data record for main results of: Adaptive study of IL-2 dose on regulatory T cells in Type 1 Diabetes (DILT1D) 

  Waldron-Lynch, Frank (University of Cambridge, 2016-01-06)

View more